Product Information
ANORO ELLIPTA 62.5-25 MCG INH is a brand product labeled by GlaxoSmithKline LLC, priced at $8.0337 per EA under NDC 00173086906. Its NADAC has been published 395 times since Nov 21, 2018.
Strength
62.5; 25 ug/1; ug/1
Manufacturer
GlaxoSmithKline LLCNDC
00173086906
Classification
Brand
Dosage Form
POWDER
Route
RESPIRATORY (INHALATION)
Last Updated
6/17/2026
Active Ingredients
UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATEApproval Type
New Drug (NDA)
FDA Application
NDA203975On Market Since
1/31/2014
Pharmacological Classes
Price Statistics
The NADAC for ANORO ELLIPTA 62.5-25 MCG INH has been published 395 times since Nov 21, 2018, and over the history we have for it it has risen 22.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.0337 per EA |
|---|---|
| All-time high | $8.0539 (Jun 11, 2025) |
| All-time low | $6.5501 (Nov 21, 2018) |
| 52-week high | $8.0452 |
| 52-week low | $8.0308 |
| Median price | $7.3720 |
| Average price | $7.4063 |
| Largest weekly change | +3.0% (Jan 9, 2019) |
| Weeks tracked | 395 |
| Tracking since | Nov 21, 2018 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 39% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ANORO ELLIPTA 62.5-25 MCG INH?
The current National Average Drug Acquisition Cost (NADAC) for ANORO ELLIPTA 62.5-25 MCG INH, manufactured by GlaxoSmithKline LLC, is $8.0337 per EA (NDC 00173086906), effective Jun 24, 2026.
How has the price of ANORO ELLIPTA 62.5-25 MCG INH changed over time?
Over the history we have for it, the NADAC for ANORO ELLIPTA 62.5-25 MCG INH has risen 22.6%. It has been tracked across 395 weekly CMS publications since Nov 21, 2018.
What are the highest and lowest recorded NADAC prices for ANORO ELLIPTA 62.5-25 MCG INH?
Since Nov 21, 2018, the NADAC for ANORO ELLIPTA 62.5-25 MCG INH has ranged from a low of $6.5501 (Nov 21, 2018) to a high of $8.0539 (Jun 11, 2025), with a median of $7.3720 per EA.
Are there cheaper alternatives to ANORO ELLIPTA 62.5-25 MCG INH?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, UMECLIDINIUM-VILANTEROL ELLIPTA 62.5-25 MCG INH, is $4.8733 per EA — about 39% below ANORO ELLIPTA 62.5-25 MCG INH.
Who manufactures ANORO ELLIPTA 62.5-25 MCG INH?
ANORO ELLIPTA 62.5-25 MCG INH (NDC 00173086906) is labeled by GlaxoSmithKline LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification